Electroporation-mediated pain-killer gene therapy for mononeuropathic rats.
about
Intramuscular electroporation with the pro-opiomelanocortin gene in rat adjuvant arthritisIntrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in ratsIn vivo electroporation mediated gene delivery to the beating heart.The use of genes for performance enhancement: doping or therapy?When the DREAM is gone: from basic science to future prospectives in pain management and beyond.Vectors for the treatment of autoimmune disease.DNA electrotransfer: its principles and an updated review of its therapeutic applications.Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain.Gene therapy applications for the treatment of neuropathic pain.Gene therapy for the treatment of chronic peripheral nervous system pain.Intrathecal injection of naked plasmid DNA provides long-term expression of secreted proteinsEquine performance genes and the future of doping in horseracing.Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control.Electrical stimulation-induced release of beta-endorphin from genetically modified neuro-2a cells.Peripheral non-viral MIDGE vector-driven delivery of beta-endorphin in inflammatory pain.Regulated, electroporation-mediated delivery of pro-opiomelanocortin gene suppresses chronic constriction injury-induced neuropathic pain in rats.Electroporation-mediated muscarinic M3 receptor gene transfer into rat urinary bladder.
P2860
Q24792890-1E7476B7-C9F1-4794-85E1-FA10EF8C3861Q25256466-FD2CE0F4-C072-41B1-BA86-41CDA4ACFF59Q30994484-D5BEF9C7-DC9C-4289-9962-B7E3E16821C6Q34227757-617061BF-45A1-4264-9BFD-82F0548B4521Q35095159-42CA7F47-3E72-4892-B3A9-25F3A1B0B560Q35122178-2923CC00-3A6E-433A-8568-467675E45B8AQ35904419-3C3B7F4C-7D65-494D-962A-8099BDB8D6FFQ36458975-C7FF5762-F2B7-4615-B9C1-297BF1BCE1FCQ36817045-FEEEDCFF-4033-4759-B29F-501846F59028Q38016275-A426B9B2-1A4F-4084-B0E9-AF057E194231Q38475446-FA32EE29-790A-4573-9777-EBAE72D68EFCQ38738678-5C00450E-97A1-447F-831B-E702BA7B1EBBQ39887680-BA402CDE-4C32-4A46-A9E7-7D9A32FD4F5CQ39948994-2E243D08-EB4D-44E8-8FCB-49413F309C94Q42948028-AC997C45-4827-436A-A166-27FB603F8776Q44872856-07EE8FD2-941A-4E11-A366-A423F1CD7088Q45127616-D03B2269-980D-45BD-8839-7F4EAE413750
P2860
Electroporation-mediated pain-killer gene therapy for mononeuropathic rats.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Electroporation-mediated pain-killer gene therapy for mononeuropathic rats.
@en
Electroporation-mediated pain-killer gene therapy for mononeuropathic rats.
@nl
type
label
Electroporation-mediated pain-killer gene therapy for mononeuropathic rats.
@en
Electroporation-mediated pain-killer gene therapy for mononeuropathic rats.
@nl
prefLabel
Electroporation-mediated pain-killer gene therapy for mononeuropathic rats.
@en
Electroporation-mediated pain-killer gene therapy for mononeuropathic rats.
@nl
P2093
P2860
P356
P1433
P1476
Electroporation-mediated pain-killer gene therapy for mononeuropathic rats.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3301790
P577
2002-09-01T00:00:00Z
P5875
P6179
1025557957